| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/07/1993 | US5268170 Administering a polypeptide |
| 12/07/1993 | CA1324970C Transformed shigella |
| 12/07/1993 | CA1324956C Stable lyophilized live herpes virus vaccine |
| 12/01/1993 | EP0572118A1 Monoclonal antibodies to GP130 protein |
| 12/01/1993 | EP0571648A1 Vaccine protecting against mycoplasmal pneumonia |
| 12/01/1993 | EP0571613A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 12/01/1993 | EP0571554A1 Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods |
| 12/01/1993 | EP0571549A1 A NOVEL INTEGRIN SPECIFICITY FOR THE HIV Tat PROTEIN |
| 12/01/1993 | EP0571538A1 Structural gene of pneumococcal protein |
| 12/01/1993 | EP0571536A1 Reagents and methods for identification of vaccines |
| 12/01/1993 | EP0571442A1 Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof |
| 12/01/1993 | EP0571410A1 Herpes simplex virus-1 deletion variants and vaccines thereof |
| 12/01/1993 | EP0571387A1 A non-mitogenic competitive hgf antagonist |
| 12/01/1993 | EP0329761B1 Hiv-1-related polypeptides, diagnostic systems and assay methods |
| 11/30/1993 | US5266689 Eimeria maxima 165 rDNA probes |
| 11/30/1993 | US5266489 Recombinant herpesviruses, in particular for the production of vaccines, process for preparing them, plasmids produced during this process and vaccines obtained |
| 11/30/1993 | US5266313 Raccoon poxvirus as a gene expression and vaccine vector for genes of rabies virus and other organisms |
| 11/25/1993 | WO1993023754A1 Process for the prenatal diagnosis of genetic abnormalities |
| 11/25/1993 | WO1993023743A1 Method of preparing a diagnostic agent for detecting inflammations |
| 11/25/1993 | WO1993023569A1 Method and reagent for inhibiting viral replication |
| 11/25/1993 | WO1993023557A1 Anti-receptor agents to the vitamin b12/transcobalamin ii receptor |
| 11/25/1993 | WO1993023549A2 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors |
| 11/25/1993 | WO1993023544A1 Fusion protein from feline leukaemia virus gp70 as vaccine |
| 11/25/1993 | WO1993023543A1 Clostridium perfringens vaccines |
| 11/25/1993 | WO1993023542A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 11/25/1993 | WO1993023427A1 Hiv protein epitopes immunologically homologous to hla |
| 11/25/1993 | WO1993023423A1 Canine coronavirus s gene and uses therefor |
| 11/25/1993 | WO1993023422A1 Compositions and methods for vaccination against coronaviruses |
| 11/25/1993 | WO1993023421A1 Universal coronavirus vaccine |
| 11/25/1993 | WO1993023081A1 Methods and agents for modulating immune response, and uses thereof |
| 11/25/1993 | WO1993023079A1 Method for nonspecific cellular immune stimulation |
| 11/25/1993 | WO1993023078A1 Vaccine for prophylaxis of marek disease of birds and method of its preparation |
| 11/25/1993 | WO1993023077A1 Vaccine for susceptible hosts against nonadapted parasites |
| 11/25/1993 | WO1993023076A1 Alternative receptor therapy |
| 11/25/1993 | WO1993023073A1 Thyroid peroxidase epitopic regions |
| 11/25/1993 | WO1993023063A1 Novel neutrophil inhibitors |
| 11/25/1993 | WO1993023062A1 Therapeutic conjugates of toxins and drugs |
| 11/25/1993 | WO1993023046A1 Enantiomeric cynemicin analogs, preparation and use thereof |
| 11/25/1993 | WO1993023031A1 Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response |
| 11/25/1993 | WO1993020852A3 Macrocyclic chelating agents, chelates and conjugates thereof |
| 11/25/1993 | WO1993019178A3 Peptides useful for inducing tolerance |
| 11/25/1993 | WO1992019743A3 Hcv genomic sequences for diagnostics and therapeutics |
| 11/25/1993 | CA2136234A1 Enantiomeric dynemicin analogs, preparation and use thereof |
| 11/25/1993 | CA2135882A1 Method of preparing a diagnostic agent for detecting inflammations |
| 11/25/1993 | CA2135784A1 Method for nonspecific cellular immune stimulation |
| 11/25/1993 | CA2135748A1 Methods and agents for modulating immune response, and uses thereof |
| 11/25/1993 | CA2135646A1 Method and reagent for inhibiting viral replication |
| 11/25/1993 | CA2135512A1 Vaccine for susceptible hosts against nonadapted parasites |
| 11/25/1993 | CA2135390A1 Novel neutrophil inhibitors |
| 11/25/1993 | CA2135201A1 Universal coronavirus vaccine |
| 11/25/1993 | CA2134898A1 Compositions and methods for vaccination against coronaviruses |
| 11/25/1993 | CA2134326A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 11/25/1993 | CA2113437A1 Fusion protein from feline leukaemia virus gp70 as vaccine |
| 11/25/1993 | CA2113194A1 Process for the prenatal diagnosis of genetic abnormalities |
| 11/24/1993 | EP0570682A1 Synthetic lipid A glycoconjugate antigens for use in vaccines |
| 11/24/1993 | EP0570509A1 Htlv-i and htlv-ii peptide antigens and methods |
| 11/24/1993 | EP0570489A1 LIVER-STAGE-SPECIFIC PEPTIDE SEQUENCES OF $i(P. FALCIPARUM) BEARING EPITOPES CAPABLE OF STIMULATING THE T LYMPHOCYTES |
| 11/24/1993 | EP0570381A1 Method for immobilization of thiol compounds via activation of polymers, activated polymers, and products obtained by the method |
| 11/24/1993 | EP0381763B1 Antibody modified with toxin |
| 11/24/1993 | CN1022839C Functionized polymine cheiants and rhodium complexes thereof and process for their preparation |
| 11/24/1993 | CN1022801C Process for the preparation of canine parvovirus vaccines |
| 11/23/1993 | US5264416 Interleukin-7 receptors |
| 11/23/1993 | US5264221 Liposomes with maleimide groups bonded to thiol groups in proteins for antitumor agents |
| 11/18/1993 | EP0570357A2 Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates |
| 11/18/1993 | EP0570027A1 T cell receptor-specific for antigen polypeptides and related polynucleotides |
| 11/18/1993 | EP0570022A2 Chelants possessing ortho ligating functionality and complexes thereof |
| 11/18/1993 | EP0569678A2 Double transfectants of MHC genes as cellular vaccines for immunoprevention of tumor metastasis |
| 11/18/1993 | EP0569537A1 Monoclonal antibodies to putative hcv envelope region and methods for using same |
| 11/18/1993 | EP0569531A1 Stabilized antibody fragments |
| 11/18/1993 | EP0569525A1 METHOD OF PRODUCING F(ab') 2? FRAGMENTS OF IMMUNOGLOBULINS |
| 11/18/1993 | EP0363449B1 Method for detecting antibodies specific for rheumatic diseases, in particular chronic polyarthritis, and reagent therefor |
| 11/18/1993 | EP0362272B1 Method and compositions for making acsf and acsf antagonists |
| 11/18/1993 | EP0332651B1 Method of isolating ca 125 antigen |
| 11/18/1993 | EP0313569B1 Enhancement of the cellular immune response |
| 11/18/1993 | EP0171407B1 Improvements relating to growth factors |
| 11/17/1993 | CN1078401A Immunotoxins directed against CD33 related surface antigens |
| 11/17/1993 | CN1078400A Method for reducing side effects of a drug |
| 11/16/1993 | US5262319 Method for obtaining bone marrow free of tumor cells using transforming growth factor β3 |
| 11/16/1993 | US5262301 Genetic engineering |
| 11/16/1993 | US5262177 Recombinant viruses encoding the human melanoma-associated antigen |
| 11/16/1993 | US5262152 Amidrazones and derivatives thereof |
| 11/16/1993 | CA1324333C Procedure for exposing an epitope within a protein possessing a distinct polypeptide structure, and the products obtained |
| 11/16/1993 | CA1324332C Empty viral capsid vaccines |
| 11/16/1993 | CA1324331C Monoclonal antibodies against e7 protein of human type 16 papillomavirus, a process for their preparation, and their use |
| 11/15/1993 | CA2095404A1 Purification and characterization of a csvtcg-specific tumor cell adhesion receptor |
| 11/11/1993 | WO1993022452A1 Measurement of an enzyme marker as an aid to diagnosis |
| 11/11/1993 | WO1993022449A1 Inhibitory factor |
| 11/11/1993 | WO1993022442A1 Oral infection of insect larvae with pre-occluded baculovirus particles |
| 11/11/1993 | WO1993022440A1 Cdna sequence of dengue virus serotype 1 (singapore strain) |
| 11/11/1993 | WO1993022437A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology |
| 11/11/1993 | WO1993022435A1 Fanconi anemia gene for complementation group c |
| 11/11/1993 | WO1993022430A1 Development of a vector to target gene expression to the epidermis of transgenic animals |
| 11/11/1993 | WO1993022429A1 Novel compositions and methods for detection and treatment of human osteoarthritis |
| 11/11/1993 | WO1993022343A1 Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom |
| 11/11/1993 | WO1993022342A1 Protein l and hybrid proteins thereof |
| 11/11/1993 | WO1993022341A1 Synthetic peptide vaccines for dental caries |
| 11/11/1993 | WO1993022340A1 Modulation of thrombospondin-cd36 interactions |
| 11/11/1993 | WO1993022338A1 Peptides of human papilloma virus for use in human t cell response inducing compositions |
| 11/11/1993 | WO1993022331A1 Human crabp-i and crabp-ii |
| 11/11/1993 | WO1993022073A1 Removal of foreign particles from alum-adsorbed products |